219 related articles for article (PubMed ID: 15692107)
1. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
[TBL] [Abstract][Full Text] [Related]
2. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
[TBL] [Abstract][Full Text] [Related]
3. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
4. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis.
Ribo M; Molina CA; Alvarez B; Rubiera M; Alvarez-Sabin J; Matas M
J Neuroimaging; 2010 Jul; 20(3):224-7. PubMed ID: 19226340
[TBL] [Abstract][Full Text] [Related]
6. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
[TBL] [Abstract][Full Text] [Related]
7. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
Alexandrov AV; Grotta JC
Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
[TBL] [Abstract][Full Text] [Related]
8. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
Rubiera M; Ribo M; Delgado-Mederos R; Santamarina E; Delgado P; Montaner J; Alvarez-Sabín J; Molina CA
Stroke; 2006 Sep; 37(9):2301-5. PubMed ID: 16888266
[TBL] [Abstract][Full Text] [Related]
9. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
[TBL] [Abstract][Full Text] [Related]
10. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke.
Felberg RA; Okon NJ; El-Mitwalli A; Burgin WS; Grotta JC; Alexandrov AV
Stroke; 2002 May; 33(5):1301-7. PubMed ID: 11988607
[TBL] [Abstract][Full Text] [Related]
11. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
12. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.
Christou I; Alexandrov AV; Burgin WS; Wojner AW; Felberg RA; Malkoff M; Grotta JC
Stroke; 2000 Aug; 31(8):1812-6. PubMed ID: 10926939
[TBL] [Abstract][Full Text] [Related]
13. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
Alexandrov AV; Wojner AW; Grotta JC;
J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
[TBL] [Abstract][Full Text] [Related]
14. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
[TBL] [Abstract][Full Text] [Related]
15. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
[TBL] [Abstract][Full Text] [Related]
16. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring.
Alexandrov AV; Demchuk AM; Felberg RA; Christou I; Barber PA; Burgin WS; Malkoff M; Wojner AW; Grotta JC
Stroke; 2000 Mar; 31(3):610-4. PubMed ID: 10700493
[TBL] [Abstract][Full Text] [Related]
17. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
18. Ischemic middle cerebral artery stroke missing the tissue plasminogen activator time window: transcranial Doppler evaluation.
Telman G; Namestnikov O; Kouperberg E; Sprecher E; Yarnitsky D
J Stroke Cerebrovasc Dis; 2008; 17(6):366-9. PubMed ID: 18984428
[TBL] [Abstract][Full Text] [Related]
19. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion.
Pagola J; Ribo M; Alvarez-Sabín J; Lange M; Rubiera M; Molina CA
Stroke; 2007 Nov; 38(11):2931-4. PubMed ID: 17901389
[TBL] [Abstract][Full Text] [Related]
20. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
